ClinicalTrials.Veeva

Menu

Enhanced External Counterpulsation on Delayed Onset Muscle Soreness

D

David Grant U.S. Air Force Medical Center

Status

Completed

Conditions

Muscle Tightness

Treatments

Device: Enhanced External Counterpulsation

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT02175316
FDG20130045H

Details and patient eligibility

About

This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.

Enrollment

18 patients

Sex

All

Ages

25 to 59 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy active Duty or DoD beneficiaries between 25 and 59 years old

Exclusion criteria

  • Not on a physical profile
  • Not taking any OTC or prescription pain medications or workout supplements

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

18 participants in 1 patient group

Experimental: EECP for DOMS
Experimental group
Description:
All enrolled subjects will receive EECP treatment Delayed Onset Muscle Soreness.
Treatment:
Device: Enhanced External Counterpulsation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems